MannKind
Established in 1991, MannKind Corporation focuses on the discovery and development of therapeutic products for patients with diseases such as diabetes, and is currently working on developing an inhaled insulin product. They are based in Danbury, Connecticut.
Last updated on
About MannKind
Founded
1991Estimated Revenue
$50M-$100MEmployees
251-1KFunding / Mkt. Cap
$1BCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
541Location
City
DanburyState
ConnecticutCountry
United StatesTech Stack (107)
